Aytu BioScience (AYTU) Misses Q3 EPS by 53c
Tweet
Share
E-mailGet Alerts AYTU Hot Sheet
Join SI Premium – FREE
Aytu BioScience (NASDAQ: AYTU) reported Q3 EPS of ($0.53). Revenue for the quarter came in at $12.4 million.
For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
